| 摘要 |
FIELD: immunology. ^ SUBSTANCE: invention refers to the area of microbiology and immunology and provides attenuated Mycoplasma gallisepticum bacteria, vaccine composition as well as methods of vaccinating an animal, which strain was deposited with the American Type Culture Collection (FNCC) and has been assigned Accession No. PTA-8485. ^ EFFECT: reduced expression of protein, identified as MGA_0621, which was shown to exhibit significantly reduced expression of MGA_0621, and was shown to be safe and effective when administered as a vaccine against M. gallisepticum infection. ^ 4 cl, 1 dwg, 5 tbl, 3 ex |
